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Abstract. Schistosomiasis prevalence data for Nigeria were extracted from peer-reviewed journals and reports, geo-refer-
enced and collated in a nationwide geographical information system database for the generation of point prevalence maps.
This exercise revealed that the disease is endemic in 35 of the country’s 36 states, including the federal capital territory of
Abuja, and found in 462 unique locations out of 833 different survey locations. Schistosoma haematobium, the predomi-
nant species in Nigeria, was found in 368 locations (79.8%) covering 31 states, S. mansoni in 78 (16.7%) locations in 22
states and S. intercalatum in 17 (3.7%) locations in two states. S. haematobium and S. mansoni were found to be co-endem-
ic in 22 states, while co-occurrence of all three species was only seen in one state (Rivers). The average prevalence for each
species at each survey location varied between 0.5% and 100% for S. haematobium, 0.2% to 87% for S. mansoni and 1%
to 10% for S. intercalatum. The estimated prevalence of S. haematobium, based on Bayesian geospatial predictive model-
ling with a set of bioclimatic variables, ranged from 0.2% to 75% with a mean prevalence of 23% for the country as a whole
(95% confidence interval (CI): 22.8-23.1%). The model suggests that the mean temperature, annual precipitation and soil
acidity significantly influence the spatial distribution. Prevalence estimates, adjusted for school-aged children in 2010,
showed that the prevalence is <10% in most states with a few reaching as high as 50%. It was estimated that 11.3 million
children require praziquantel annually (95% CI: 10.3-12.2 million). 
Keywords: schistosomiasis, prevalence, geo-referencing, geographical information system, risk mapping, Bayesian geospatial
modelling, control, Nigeria.
Introduction
More than 200 million people are thought to be
infected with Schistosoma spp., with more than 95%
of all infections concentrated in Africa (Steinmann et
al., 2006; Utzinger et al., 2009). Due to the require-
ment of an intermediate snail host, this trematode par-
asite thrives in areas characterised by poor sanitation
and hygiene, poverty and general neglect, where rivers,
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lakes and irrigation schemes facilitate its continued
transmission (WHO, 2002; Gryseels et al., 2006;
Hotez and Kamath, 2009; Stothard et al., 2009;
Utzinger et al., 2011).
Schistosomiasis has been classified as a neglected
tropical disease (NTD), although an estimated 779
million people in the world are at risk for it according
to relatively recent surveys (Steinmann et al., 2006;
Hotez et al., 2007a). Three species (S. mansoni,
S. haematobium and S. intercalatum) are endemic in
Nigeria, which led to the formation of a national
schistosomiasis control programme in the late 1980s.
However, due to lack of political will and inadequate
funding for control activities, the burden of schisto-
somiasis did not decline. Estimates in the mid-1990s
suggested that more than 100 million people were at
risk for this disease and that 25.8 million people were
actually infected (Chitsulo et al., 2000). More recent-
ly, the latter figure was updated to 29 million infec-
tions (Steinmann et al., 2006; Moné et al., 2010),
which corresponds to 14% of the global number of
Schistosoma infections and puts Nigeria at the top of
the list of endemic countries. To date, concerted
efforts to control schistosomiasis in Nigeria have
failed, not only due to the reasons given above, but
also because reliable data regarding its geographical
distribution are lacking. The paucity of empirical
schistosomiasis estimates and endemic foci within
states and local government areas (LGAs), the units
usually used for health interventions, have proved a
major impediment for the national control pro-
gramme. Attempts to provide risk estimates at these
units remain sporadic, but some information is avail-
able, e.g. from the state of Niger (Mafe et al., 2000)
and more recently from the state of Ogun (Ekpo et
al., 2008).
Several sub-Saharan African countries have
received support from United Nations (UN) and non-
governmental organizations (NGOs) to control schis-
tosomiasis along with other NTDs (Hotez et al.,
2007b). Nigeria, however, has only received limited
international support due to absence of governmen-
tal commitment and reliable empirical data. Given
the large population of the country and the high fre-
quency of NTDs, including schistosomiasis, this situ-
ation will only change when the current neglect is
translated into proactive action (Hotez et al., 2012).
The ongoing global move to control and eventually
eliminate the NTDs (IPPPH, 2009; BMGF, 2010;
Utzinger, 2012; WHO, 2012; Rollinson et al., 2013)
will likely result in many African nations receiving
support to implement national control programmes.
Data compiled by the “Global Neglected Tropical
Diseases” (GNTD) database (Hürlimann et al.,
2011), supplemented with local geo-referenced sur-
vey data, will be helpful in this context. The work
presented here was undertaken to help move the
Nigerian schistosomiasis control programme for-
ward by updating maps on the geographical distribu-
tion of the disease. 
Methods
Literature review
A comprehensive literature review related to schis-
tosomiasis survey data in Nigeria, using PubMed and
other readily available bibliographic databases, was
conducted under the umbrella of the EU-funded
CONTRAST project (Kristensen, 2008). Details of
how the GNTD database was established, including
standard protocols for data extraction of relevant lit-
erature, have been presented elsewhere (Hürlimann et
al., 2011). Additional specific searches were per-
formed based on references from the retrieved publi-
cations. Websites of international organization, such
as the World Health Organization (WHO) and the
United Nations Children’s Fund (UNICEF), were also
consulted for schistosomiasis survey data and the
Federal Ministry of Health, State Ministries of Health,
NGOs, universities and local research institutions in
Nigeria were contacted. Relevant data, including the
number of those examined, age groups surveyed,
Schistosoma species, sex ratio, diagnostic method,
study approach and study location, were extracted
and collated in a standardised database.
Geo-referencing of identified survey data
Data compiled in the GNTD database, supplement-
ed with recent surveys and reports obtained from the
aforementioned sources were analysed. For a detailed
description of the various data sources, the data
extraction process, the database system and internal
quality checks, the reader is invited to consult recent-
ly published papers, e.g. Hürlimann et al. (2011)
Schur et al. (2013) and Stensgaard et al. (2013).
Studies lacking information about the geographical
coordinates of survey locations were retrospectively
geo-referenced using a variety of sources, such as
GEOnet Names Servers (http://earth-
info.nga.mil/gns/html/index.html) and Google maps
(http://maps.google.com). If this was not possible, the
reported locations were visited for geo-referencing
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using a hand-held global positioning system (GPS)
receiver (Garmin Etrex, Garmin Corporation, USA).
The analyses presented here are restricted to school
children of the 5 to 14 years age group and non-hos-
pital records.
Population data
Population data at the 1 km2 spatial resolution in
Nigeria for 2010 were obtained from the AfriPop pop-
ulation database (http://www.clas.ufl.edu/users/atatem/
index_files/Nigeria.htm). The total population count
for 2010 was 150,511,635 persons. The number of
school-aged children in Nigeria in 2010 was comput-
ed to be 40,337,118, which represents 26.8% of the
total population count based on information in the
international database of the United States Census
Bureau (http://www.census.gov/population/ interna-
tional/data/idb/region.php). 
Mapping and Bayesian geospatial modelling of
S. haematobium presence
Climatic and environmental data, going back to the
1950s, were obtained from the WorldClim-Global
Climatic Data source (http://worldclim.org/bioclim);
the Earth Resources Observation (EROS) centre
(http://eros.usgs.gov), and the International Soil
Reference and Information Centre (ISRIC)
(http://www.isric.org).
With regard to geospatial modelling, we first carried
out bivariate logistic regressions to determine the rela-
tionship between the risk of S. haematobium infection
and the potential climatic and environmental vari-
ables. Next, Bayesian geostatistical logistic regression
models with location-specfic random effects were fit-
ted to identify the most significant predictors using
advanced variable selection procedures (Schur et al.,
2013). Bayesian geostatistical models, fitted by
Markov chain Monte Carlo (MCMC) simulation
methods (Diggle et al., 1998) were employed to esti-
mate infection risk of S. haematobium at unobserved
locations via joint Bayesian kriging. A grid of predic-
tion locations with a spatial resolution of 5 x 5 km
was used, resulting in 30,051 pixels.
School-aged population infected with Schistosoma
The total population data grid map with 1 x 1 km
spatial resolution was rescaled to a 5 x 5 km resolu-
tion grid using the geographical information system
(GIS) software ArcMap version 9.2 (ESRI, Redlands,
CA, USA) to match the spatial resolution of the geo-
statistical S. haematobium risk estimates for Nigeria.
Population counts were linked to the percentage of
school-aged children within each predicted pixel
level. The estimated number of infected school-aged
children with S. haematobium infection was calculat-
ed by combining the median predictive posterior dis-
tribution of the infection prevalence predicted at the
pixel level with the population size of that age group
within that pixel. The median predictive posterior
distribution of the number of infected school-aged
children per state was estimated by summing up the
pixel-samples within each state and calculating sum-
mary statistics. The calculation was carried out as
follows: assuming that the pixel value of the popula-
tion data grid at location x=a, then the estimated
school-aged population y at location x is 26.8 (the
percentage share of the population accepted to con-
sist of children) divided by 100 multiplied by a.
Therefore the number of infected school-aged popu-
lation is the summed values of y1, y2, ..., yn, where the
predicted S. haematobium pixel value is greater than
zero. 
Data aggregation by state and praziquantel treatment
requirement
The national schistosomiasis control programme in
Nigeria is implemented by the State Ministries of
Health and NGOs under the supervision of the
Federal Ministry of Health. Shape files containing geo-
graphical information by state administrative bound-
aries were linked in ArcMap with S. haematobium risk
estimates and school-aged populations to estimate the
number of infected children at the pixel-level.
Population-adjusted prevalence estimates at the state
level were calculated by summing all infected school-
aged children at the pixel-level and dividing by the
total school-aged population by state.
Praziquantel, the drug used for treatment of schisto-
somiasis, is usually administered as a single oral dose of
40 mg/kg (WHO, 2006; Doenhoff et al., 2008). The
drug requirements were computed using the estimated
number of infected school-aged children and multiply-
ing by the estimated number of praziquantel tablets
needed per child. Based on guidelines put forth by
WHO (2006), the average school-aged child requires
three tablets used as a single treatment every year in
moderate endemicity settings (prevalence of 10-50%).
The treatment needs were calculated for each state for
the year 2010 following the same approach as recently
presented by Schur et al. (2012).
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Fig. 1. Time-period of included georeferenced schistosomiasis prevalence surveys in Nigeria.
Results
Temporal analysis of schistosomiasis survey data in
Nigeria
An overview of the points in time when schistosomi-
asis surveys were conducted in Nigeria is given in Fig.
1. The first surveys pertaining to schistosomiasis were
carried out in Nigeria before its independence in 1960.
Later on, particularly between 1986 and 1990, a con-
siderable number of surveys were done as the govern-
ment had a growing interest in disease control at that
time. This resulted in the establishment of the first
national schistosomiasis control programme in 1988
(Federal Ministry of Health, 1997). However, the fail-
ure of the control programme to implement large-scale
control activities led to a decrease of surveys between
1992 and 2003. The spike in reported surveys in 2004
may be due to particular activities that year by differ-
ent NGOs, most importantly the Carter Center
(http://www.cartercenter.org/index.html) (Eigege et
al., 2008; Njepuome et al., 2009). Since 2006, the
number of surveys has increased steadily as the
prospect of new initiatives to control schistosomiasis
as part of packages targeting additional, multiple
NTDs (e.g. onchocerciasis, lymphatic filariasis and
soil-transmitted helminthiasis) became reality.
Geographical distribution of schistosomiasis in
Nigeria
Schistosomiasis is endemic in all but one of the 36
states of Nigeria. The Akwa Ibom State in the south-
ern part of the country is the only state where, to date,
no endemic foci of either S. haematobium or S. man-
soni has been reported. Our empirical data reveal that
S. haematobium is the predominant species in the
country, accounting for 79.8% of all reported cases,
while the rate of S. mansoni reached 16.7% and that
of S. intercalatum 3.7%. Fig. 2 shows the map of
Nigeria depicting its states and Abuja. Fig. 3 shows the
distribution of all georeferenced survey locations in
Nigeria with Schistosoma infections. S. haematobium
and S. mansoni are both endemic in northern and
southern Nigeria, while S. intercalatum has only been
reported from the states of Bayelsa and Rivers in the
Niger delta. In the 22 states where S. mansoni exists,
S. haematobium is co-endemic, but co-distribution of
all three Schistosoma species (i.e. S. haematobium,
S. mansoni and S. intercalatum) has only been report-
ed from the state of Rivers.
S. haematobium is the most prevalent of the three
species among school-aged children and it often
exceeds the high-endemicity threshold of 50% preva-
lence. Although this infection is comparatively more
frequent in the South, it is also widespred in the rest
of the country in contrast to S. mansoni infections,
which are clearly more common in the northern half
of the country. There are also differences with respect
to intensity of disease as can be seen in Figs. 4-6,
which show the geographical distribution of the three
schistosome species in Nigeria, according to the
WHO (2002) classification of schistosomiasis rates of
prevalence (i.e. 0.1-9.9%, low prevalence; 10.0-
49.9%, moderate prevalence; and ≥50%, high preva-
lence). 
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Fig. 2. Map of Nigeria showing the 36 states and the federal capital territory (FCT) of Abuja.
Fig. 3. Geographical distribution of reported schistosomiasis cases in Nigeria, stratified by the three existing Schistosoma species.
S. haematobium risk maps
The geostatistical model for S. haematobium suggests
that the annual mean temperature, annual precipitation,
precipitation seasonality and soil acidity are associated
with S. haematobium risk in Nigeria. The parameter
estimates included in Table 1 indicate that these vari-
ables were significant covariates in the final model, as
their values from 25% SD to 75% SD includes zero. 
The spatial distribution of S. haematobium risk
throughout the country is shown in Fig. 7. Areas of
high infection risk (>50%) were predicted for loca-
tions around the Niger and Benue rivers, as well as
locations near the Lake Chad basin. Moreover, high
risk areas were identified in the south-western and
north-western parts of Nigeria. The map of the pre-
diction error for S. haematobium shows that areas of
relatively high uncertainty (75% quintile) are concen-
trated in areas of high infection risk, whereas areas of
low uncertainty (25% quintile) are mainly found in
low-risk areas. Aggregated prevalence levels for each
state are shown in Fig. 8A. States with a moderate
infection risk are Sokoto, Kebbi, Kwara, Niger,
Zamfara and Kogi. Additionally, states along Benue
River (Benue, Taraba, Nasarawa, FCT and Adamawa)
and in the Lake Chad basin area (Bornu and Yobe)
showed moderate infection prevalence. Other inland
areas of moderate risk for S. haematobium include the
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Fig. 4. Observed prevalence of S. haematobium in Nigeria including 368 georeferenced survey locations.
Fig. 5. Observed prevalence of S. mansoni in Nigeria including 78 georeferenced survey locations.
Fig. 6. Observed prevalence of S. intercalatum in Nigeria including 17 georeferenced survey locations.
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Variable Mean SD 25% SD Median 75% SD
Annual mean temperature
Annual precipitation
Precipitation seasonality
Soil acidity
0.459
-1.071
-0.596
0.533
0.336
0.420
0.589
0.297
0.148
-1.641
-1.100
-0.341
0.382
-1.129
-0.715
0.581
1.675
0.064
1.698
0.951
Table 1. Model parameter estimates for S. haematobium in Nigeria using Bayesian regression.
SD, standard deviation
Fig. 7. The predicted median posterior distribution of infection risk of S. haematobium in Nigeria based on Bayesian geostatistics
and predicted error maps.
states Ogun, Oyo and Osun in the south-western part of
the country. Areas of low risk (<10%) were found in the
southern part of Nigeria (i.e. the states of Delta, Edo,
Enugu, Anambra and Ebonyi) and in the northern part
(i.e. Plateau, Gombe, Bauchi, Kaduna and Katsina).
There are, however, also low-risk states in the Niger
delta, e.g. Rivers, Imo, Abia, Akwa Ibom, Bayelsa and
the southern parts of Cross River. The map reveals that
most of the states in Nigeria are characterised by either
low or moderate risk with no state considered to be at
high risk. Still, high-risk communities with prevalence
in excess of 50% were found in several states (Fig. 8B).
School-aged population infected and treatment
requirements
State-specific estimates of the number of school-
aged children infected with Schistosoma, and hence
requiring praziquantel treatment as of 2010 are
shown in Table 2. The results suggest that the total
number of infected school-aged children in Nigeria is
11.3 million (95% confidence interval (CI): 10.3-12.2
million). The state of Anamabra in southern Nigeria
was found to have the highest number of infected
school-aged children, while the Enugu state in the
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Fig. 8. Prevalence estimates of S. haematobium for the 36 states in Nigeria including the federal capital territory (FCT) of Abuja.
Prevalences (based on the 2002 WHO classification) are shown at the state level (A) and the pixel level (B).
same region had the lowest. The number of prazi-
quantel tablets required for treating the predicted
number of school-aged children was estimated at 34
million tablets for 2010.
Discussion
The paucity of detailed information on schistoso-
miasis distribution in Nigeria hampers the imple-
mentation of the national control programme. Risk
maps were produced to facilitate the targeting of
schistosomiasis control activities, planning of future
surveys and surveillance. The first detailed hard-copy
maps of the global distribution of schistosomiasis
were published a quarter century ago (Doumenge et
al., 1987). With the advent of desktop GIS and map-
ping software, the application of GIS for creating
digital disease maps became feasible and these
proved extremely useful for the planning, control
and surveillance of human helminth infections
(Brooker and Michael, 2000; Brooker et al., 2000,
2009, 2010; Simoonga et al., 2009). However, with
the exception of a single state, Ogun (Ekpo et al.,
2008) and despite several surveys pertaining to the
distribution of schistosomiasis and the intermediate
host snails in Nigeria, the first ones dating back to
the 1930s (Ramsay, 1934; Cowper 1963, 1973;
WHO, 1985), the compilation of these records into a
comprehensive GIS-based overview did not exist
before the current study.
In 2010, a project known as the “Global Atlas of
Helminth Infections” (GAHI; http://www.this-
wormyworld.org) started to offer digital maps on the
spatial distribution of helminth infection in sub-
Saharan Africa, including Nigeria. However, only
maps of the observed prevalence at compiled survey
locations are available (Brooker et al., 2010) and the
underlying survey data are not provided for in-depth
analyses. In 2011, the open-access GNTD database
containing georeferenced schistosomiasis prevalence
data was launched to fill this gap. This database
allows extraction of compiled prevalence data from
various published and unpublished sources for many
different countries (Hürlimann et al., 2011), which
stimulated spatially explicit analyses, such as risk
mapping, studies of the distribution of intermediate
host snails and estimates of treatment needs for the
school-aged population (Schur et al., 2011, 2012,
2013; Stensgaard et al., 2013). Employing this rich
source of schistosomiasis survey data, the geograph-
ical distributions of the three human Schistosoma
species that occur in Nigeria have been mapped.
High-risk areas have been identified allowing priori-
tization of areas warranting control interventions.
The data also permit temporal analyses, which
should assist the planning of future surveys. The cur-
rent priority would be to focus on areas where data
are particularly sparse so that cost-effectiveness of
mapping and subsequent control interventions can be
enhanced.
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S/N State Population
School-aged
childrena
Numbers
infected
95% CI Prevalenceb
PZQ tablets
required
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
Abia
Adamawa
Akwa Ibom
Anambra
Bauchi
Bayelsa
Benue
Bornu
Cross River
Delta
Ebonyi
Edo
Ekiti
Enugu
Abuja*
Gombe
Imo
Jigawa
Kaduna
Kano
Katsina
Kebbi
Kogi
Kwara
Lagos
Nasarawa
Niger
Ogun
Ondo
Osun
Oyo
Plateau
Rivers
Sokoto
Taraba
Yobe
Zamfara
Total
3,088,489
3,345,139
4,079,860
4,554,555
4,904,861
1,764,882
4,489,165
4,458,940
3,059,240
4,367,659
2,301,621
3,498,159
2,580,707
3,461,328
1,490,699
2,504,758
4,125,237
4,638,479
6,529,746
10,215,494
6,186,868
3,442,422
3,521,364
2,558,692
10,518,608
1,966,300
4,187,613
4,120,568
3,708,369
3,761,319
6,139,127
3,400,482
5,316,003
3,954,209
2,385,772
2,475,468
3,409,431
150,511,635
827,715
896,497
1,093,403
1,220,621
1,314,503
472,989
1,203,096
1,194,996
819,876
1,170,533
616,834
937,507
691,630
927,636
399,507
671,275
1,105,563
1,243,112
1,749,972
2,737,752
1,658,081
922,569
943,726
685,729
2,818,987
526,968
1,122,280
1,104,312
993,843
1,008,034
1,645,286
911,329
1,424,689
1,059,728
639,387
663,425
913,728
40,337,118
217,860
264,130
268,540
419,070
377,820
140,330
327,020
320,720
181,730
408,840
113,330
245,390
252,000
132,180
114,410
157,520
362,510
397,130
405,680
979,360
607,710
287,040
307,490
250,590
605,610
135,250
304,400
256,540
265,080
317,570
375,570
214,350
409,620
282,900
182,660
143,130
238,660
11,270,720
93,415-342,301
194,336-333,924
143-088-393,992
268,378-569,762
195,112-560,528
793,312-201,387
234,170-419,870
214,734-426,706
124,771-238,689
256,895-560,785
84,650-142,009
158,146-332,634
110,248-393,752
83,934-180,426
62,293-166,527
103,704-211,336
197,502-527,519
192,366-601,894
319,280-492,080
588,134-137,059
382,804-832,616
199,605-374,475
145,307-469,673
140,882-360,298
196,764-1,014,456
108,667-161,833
237,572-371,228
161,192-351,886
162,334-367,826
157,996-476,004
253,224-497,916
180,740-247,960
117,376-701,864
168,807-396,993
137,065-228,255
95,624-190,636
152,239-325,081
10,339,510-12,198,830
28.9
27.9
24.9
37.5
26.4
29.3
25.2
25.6
22.5
36.5
17.8
28.8
37.3
15.4
32.9
21.5
34.5
30.4
22.3
34.1
34.3
28.3
31.6
36.7
30.5
24.6
25.7
26.0
27.4
33.7
24.6
22.6
29.6
25.4
26.7
20.1
23.8
27.9
653,580
792,390
805,620
1,257,210
1,133,460
420,990
981,060
962,160
545,190
1,226,520
339,990
736,170
756,000
396,540
343,230
472,560
1,087,530
1,191,390
1,217,040
2,938,080
1,823,130
861,120
922,470
751,770
1,816,830
405,750
913,200
769,620
795,240
952,710
1,126,710
643,050
1,228,860
848,700
547,980
429,390
715,980
33,812,160
Table 2. The numbers of school-aged children infected with S. haematobium and the praziquantel (PZQ) treatment requirements in
2010 shown by state.
aComputation based on 26.8% U.S. Census Bureau international database estimate; badjusted to school-aged population; *The fed-
eral capital territory of Abuja is considered equivalent of a state
The data used in the current analyses were extracted
from peer-reviewed publications and a variety of
reports, and hence differ with regard to survey dates,
the diagnostic method used and the populations sur-
veyed. To minimise bias, we restricted our analysis to
surveys focussing on school-aged children (5-14
years), who constitute the target group for preventive
chemotherapy in schistosomiasis control programmes
(WHO, 2002, 2006). We present the first smooth
empirical risk map for S. haematobium across Nigeria
at a spatial resolution of 5 x 5 km. Previous mapping
efforts using remotely sensed climatic variables have
been based on data from the Moderate-Resolution
Imaging Spectroradiometer (MODIS) satellites data
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archives (http://wist.echo.nasa.gov) (Schur et al.,
2011, 2013). We used readily available BioClim data
dating back to the 1950s and employed advanced vari-
able selection methods. 
In the current analysis, we estimated the number of
school-aged children infected with S. haematobium to
be 11.3 million, which corresponds to 34 million praz-
iquantel tablets for their treatment. The estimates
might be slightly higher if the other two Schistosoma
species (i.e. S. mansoni and S. intercalatum) were con-
sidered as well (Schur et al., 2012). Giving the average
annual population growth rate for Nigeria to be
2.5%, the required number of praziquantel tablets
might increase every year by a percentage close to that
ot the growth rate. As several international donors
have shown interest in supplying the drug for free,
only the cost for distribution and other logistic
requirements need to be considered to calculate the
cost-effectiveness of this preventive chemotherapy
strategy. Nevertheless, the provision of data such as
presented here will enable the national control pro-
gramme to leverage evidence-based information for
sourcing of funds. As more geostatistical model-based
analysis from the GNTD database will become avail-
able for Nigeria and elsewhere, it is our hope that con-
trol of schistosomiasis in Nigeria and indeed Africa
will be accelerated, as reliable risk estimates at high
spatial resolution will reduce the cost of parasitologi-
cal surveys.
Schistosomiasis is a focal disease depending entirely
on freshwater systems harbouring the intermediate
host snails. Moreover, human activities (e.g. bathing,
washing and fishing) promote contacts with infested
water, since excreted parasite eggs must reach fresh-
water sources, hatch and penetrate a suitable snail
intermediate host (Lengeler et al., 2002; Brooker et al.,
2009; Utzinger et al., 2011). Therefore, any reduction
in the prevalence of infection in areas without
chemotherapeutic intervention can only be due to
improvement in any or all of the following: water sup-
ply and sanitation and/or health education and aware-
ness and avoidance of transmission sites. It is note-
worthy that these preventive control measures are still
often neglected in Nigeria. Indeed, effective control
measures have been demonstrated in very limited
areas such as in Plateau and Nasarawa states in north-
central Nigeria (Hopkins et al., 2002; Njepuome et al.,
2009). Thus the endemic foci documented in this
analysis are still relevant for control. Therefore, stake-
holders interested in schistosomiasis control might
find the data, provided maps and endemic foci useful
for their operational purposes.
Conclusion
Based on data compiled from the GNTD database
supplemented with local data for the creation of point
prevalence maps, we performed model-based Bayesian
geostatistical estimation of schistosomiasis infection
prevalence for unobserved locations and computed the
number of infected school-aged children and prazi-
quantel treatment requirement for Nigeria. This
should accelerate control activities and help attract
resources to implement a sustainable control pro-
gramme capable of reducing the burden of schistoso-
miasis in Nigeria.
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